Prostate-Specific Membrane Antigen–Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer

Radiohalogenated agents are often the first line of pursuit in the development of new radiopharmaceuticals—whether antibodies, peptides, or small molecules—because of their ease of synthesis, lack of substantial steric perturbation of the original affinity agent (in some cases, providing enhanced af...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Nucl Med
Главные авторы: Rowe, Steven P., Drzezga, Alexander, Neumaier, Bernd, Dietlein, Markus, Gorin, Michael A., Zalutsky, Michael R., Pomper, Martin G.
Формат: Artigo
Язык:Inglês
Опубликовано: Society of Nuclear Medicine 2016
Предметы:
Supplement
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5093916/
https://ncbi.nlm.nih.gov/pubmed/27694179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.115.170175
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы